Evidence map›Paper›PMID 41503124›Full record

ArticleBlood vessels, thrombosis & hemostasis2026

Automated natural language processing to identify venous thromboembolism from diagnostic imaging reports.

Naveen Subramanian, Hector Garcia Pleitez, Daniel Nguyen, Denái R Milton, Partow Kebriaei, Elizabeth Shpall, Lee Cheng, Jing Lu, Shida Jin, Carol C Wu and 5 more

Abstract read
In one paragraph

Article in Blood vessels, thrombosis & hemostasis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Naveen SubramanianDepartment of Internal Medicine, The University of Texas McGovern Medical School, Houston, TX.
Hector Garcia PleitezDepartment of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.
Daniel NguyenDepartment of Internal Medicine, The University of Texas McGovern Medical School, Houston, TX.
Denái R MiltonDepartment of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX.
Partow KebriaeiDepartment of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX.
Elizabeth ShpallDepartment of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX.
Lee ChengOffice of Quality & Value, Institute for Cancer Care Innovation, The University of Texas MD Anderson Cancer Center, Houston, TX.
Jing LuEnterprise Development and Integration, The University of Texas MD Anderson Cancer Center, Houston, TX.
Shida JinEnterprise Development and Integration, The University of Texas MD Anderson Cancer Center, Houston, TX.
Carol C WuDepartment of Thoracic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX.
Rahul A ShethDepartment of Interventional Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Alessandra FerrajoliDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
Katy M ToaleDepartment of Pharmacy Quality and Regulatory, The University of Texas MD Anderson Cancer Center, Houston, TX.
Michael H KrollDivision of Internal Medicine, Section of Benign Hematology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Cristhiam M Rojas-HernandezDivision of Internal Medicine, Section of Benign Hematology, The University of Texas MD Anderson Cancer Center, Houston, TX.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The annual incidence of venous thromboembolism (VTE) may be 50-fold increased after allogeneic hematopoietic stem cell transplant (HSCT). Such incidence data, as well as data that establish clinical variables resulting in this enhanced risk, have generally required manual chart review. This cumbersome process can be improved by natural language processing (NLP) algorithms designed to detect VTE in electronic medical record systems. We describe the development of an institutional NLP algorithm for VTE detection, and our evaluation of its performance in detecting VTE in patients who recently underwent HSCT. We retrospectively reviewed adult patients between 2016 and 2020. NLP assessed patient records for acute VTE within 100 days of HSCT, and manual chart review was performed for comparison. NLP sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were calculated. A total of 1300 electronic health records were analyzed. The 100-day VTE incidence rate as determined via manual chart review and NLP was 10.3% and 8.8%, respectively. NLP's specificity, sensitivity, PPV, and NPV were >0.85. Of the 19 events not identified by NLP, all were found in radiology or vascular laboratory reports overlooked by NLP. These results demonstrate excellent performance of NLP for identifying VTE in HSCT patients. Future refinement of NLP, and its combination with other detection methods should provide better detection of VTE in this and other at-risk cohorts.

Identifiers

PMID41503124
PMCPMC12768905

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.